Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
Follow-Up Questions
¿Quién es el CEO de Advanced Biomedical Technologies Inc?
Ms. Hui Wang es el Chief Executive Officer de Advanced Biomedical Technologies Inc, se unió a la empresa desde 2009.
¿Qué tal es el rendimiento del precio de la acción ABMT?
El precio actual de ABMT es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Advanced Biomedical Technologies Inc?
Advanced Biomedical Technologies Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Advanced Biomedical Technologies Inc?
La capitalización bursátil actual de Advanced Biomedical Technologies Inc es $0
